Sandoz | search
Click here to view Sandoz news from 60+ newspapers.
Bookmark or Share- Novartis executes Sandoz Spin-off, completing strategic ...Novartis executes separation of the Sandoz business to create an independent company by way of a 100% Spin-off. Shares of Sandoz will be listed and commence trading today on the SIX Swiss Exchange.
- Sandoz spin-off | NovartisSandoz planned spin-off updates at Novartis Q2 2023 Financial Results. The Novartis Board of Directors has unanimously endorsed the proposed separation of Sandoz to create an independent company by way of a 100% spin-off.
- SandozSandoz is a global leader in generic pharmaceuticals and biosimilars, with a mission to discover new ways to improve and extend people's lives. Learn more about our products, our quality standards, our innovation and sustainability efforts, and our partnerships and collaborations.
- Sandoz - WikipediaSandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.
- Sandoz receives FDA approval for first and only denosumab ...Basel, March 5, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) approved Wyost ® (denosumab-bbdz) and ...
More
